Long-term prophylactic treatment preferences and willingness to switch therapy in individuals with hereditary angioedema
Effectiveness was the primary driver of LTP preference; other factors were also important, including convenience. When effectiveness was equivalent, oral administration was preferred to injectable administration. Individuals with HAE were moderately willing to switch their LTP. By better understanding patients' treatment preferences, health care professionals can individualize LTP recommendations.
Authors
- Daniel Soteres (ORCID: https://orcid.org/0000-0002-7433-0171)
- Christine Poulos (ORCID: https://orcid.org/0000-0001-7810-3411)
- Marco Lionetti
- Tamara Ray
- Sandra Nestler-Parr
- Lorena López-González (ORCID: https://orcid.org/0000-0002-2589-9935)
- Courtney Olson
- Patrick Gillard
Institutions
- Beth Israel Deaconess Medical Center (US)
- Gastroenterology Group of Rochester (US)
- BioCryst Pharmaceuticals (United States) (US)
- RTI Health Solutions (US)
- Allergy Associates Research Center (US)
Publication Details
- Journal
- Annals of Allergy Asthma & Immunology
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1016/j.anai.2025.12.011
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- BioCryst